- Filed
- Nov 26, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Oct 31, 2025 | 268.63M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2025 | 269.7M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2024 | 268.55M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2024 | 268.94M sh |
| Stock Repurchased | Q3 2025 · Oct 31, 2025 | $1.39B |
| Stock Repurchased | Q3 2025 · Oct 31, 2024 | $597M |
| Capex | Q3 2025 · Oct 31, 2025 | $102M |
| Capex | Q3 2025 · Oct 31, 2024 | $183M |
| Operating Cash Flow | Q3 2025 · Oct 31, 2025 | $1.66B |
| Operating Cash Flow | Q3 2025 · Oct 31, 2024 | $1.35B |
| Long Term Debt | Q3 2025 · Oct 31, 2025 | $2.99B |
| Long Term Debt | Q3 2025 · Jan 31, 2025 | $2.98B |
| Cash And Equivalents | Q3 2025 · Oct 31, 2025 | $2.61B |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $1.54B |
| Cash And Equivalents | Q3 2025 · Oct 31, 2024 | $1.31B |
| Stockholders Equity | Q3 2025 · Oct 31, 2025 | $8.88B |
| Stockholders Equity | Q3 2025 · Jan 31, 2025 | $9.03B |
| Stockholders Equity | Q3 2025 · Oct 31, 2024 | $8.62B |
| Current Liabilities | Q3 2025 · Oct 31, 2025 | $5.02B |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $5.55B |
| Total Liabilities | Q3 2025 · Oct 31, 2025 | $8.87B |
| Total Liabilities | Q3 2025 · Jan 31, 2025 | $8.94B |
| Current Assets | Q3 2025 · Oct 31, 2025 | $9.18B |
| Current Assets | Q3 2025 · Jan 31, 2025 | $10.55B |
| Total Assets | Q3 2025 · Oct 31, 2025 | $17.75B |
| Total Assets | Q3 2025 · Jan 31, 2025 | $17.98B |
| Eps Diluted | Q3 2025 · Oct 31, 2025 | $0.94 |
| Eps Diluted | Q3 2025 · Oct 31, 2025 | $2.03 |
| Eps Diluted | Q3 2025 · Oct 31, 2024 | $0.72 |
| Eps Diluted | Q3 2025 · Oct 31, 2024 | $1.61 |
| Eps Basic | Q3 2025 · Oct 31, 2025 | $0.95 |
| Eps Basic | Q3 2025 · Oct 31, 2025 | $2.06 |
| Eps Basic | Q3 2025 · Oct 31, 2024 | $0.73 |
| Eps Basic | Q3 2025 · Oct 31, 2024 | $1.63 |
| Sga Expense | Q3 2025 · Oct 31, 2025 | $234M |
| Sga Expense | Q3 2025 · Oct 31, 2025 | $662M |
| Sga Expense | Q3 2025 · Oct 31, 2024 | $198M |
| Sga Expense restated | Q3 2025 · Oct 31, 2024 | $600M |
| Rd Expense | Q3 2025 · Oct 31, 2025 | $666M |
| Rd Expense | Q3 2025 · Oct 31, 2025 | $1.99B |
| Rd Expense | Q3 2025 · Oct 31, 2024 | $647M |
| Rd Expense | Q3 2025 · Oct 31, 2024 | $1.95B |
| Net Income | Q3 2025 · Oct 31, 2025 | $252M |
| Net Income | Q3 2025 · Oct 31, 2025 | $548M |
| Net Income | Q3 2025 · Oct 31, 2024 | $193M |
| Net Income | Q3 2025 · Oct 31, 2024 | $432M |
| Operating Income | Q3 2025 · Oct 31, 2025 | $259M |
| Operating Income | Q3 2025 · Oct 31, 2025 | $547M |
| Operating Income | Q3 2025 · Oct 31, 2024 | $165M |
| Operating Income | Q3 2025 · Oct 31, 2024 | $340M |
| Revenue | Q3 2025 · Oct 31, 2025 | $2.43B |
| Revenue | Q3 2025 · Oct 31, 2025 | $7.02B |
| Revenue | Q3 2025 · Oct 31, 2024 | $2.16B |
| Revenue | Q3 2025 · Oct 31, 2024 | $6.24B |